| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109.7M | +2.4% | +31.6% |
| Cost of Revenue | $66.6M | +2.1% | +29.8% |
| Gross Profit | $43.1M | +2.7% | +34.5% |
| R&D Expense | $23.1M | +1.7% | +4.4% |
| SG&A Expense | $21.2M | +9.5% | +23.7% |
| Operating Income | -$18.9M | -17.3% | +8.7% |
| Pre-tax Income | -$36.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $378.2M | — | — |
| Accounts Receivable | $84.3M | — | — |
| Current Assets | $478.9M | — | — |
| Total Assets | $702.1M | — | — |
| Current Liabilities | $92.7M | — | — |
| Total Liabilities | $127.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.4M | — | — |
| Capital Expenditures | $1.3M | — | — |
| Investing Cash Flow | -$4.6M | — | — |
| Financing Cash Flow | $333.9M | — | — |
| Free Cash Flow | -$31.8M | — | — |
| -78.9% |
| -74.3% |
| Income Tax | $490K | -43.8% | +22.8% |
| Net Income | -$36.9M | -73.8% | -73.0% |
| EPS (Basic) | -$1.49 | +9.7% | +12.4% |
| EPS (Diluted) | -$1.49 | +9.7% | +12.4% |
| — |
| Stockholders' Equity | $574.6M | +157.3% | +159.3% |